In contrast, there was decreased p18Ink4c expression in Irbp-Cyclin D1, p53-/- tumors, suggesting that p18Ink4c may act as a tumor suppressor, even in a p53-null setting [Figure 5D, 5F]. This evidence concerns the gene TP53 and neoplasm.